Drug
Intravenous HES
Intravenous HES is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Other(3)
Detailed Status
unknown3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed125%
unknown375%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity
NCT02700607
unknownnot_applicable
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for Colon Surgery
NCT02770027
unknownnot_applicable
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for Cardiac Surgery
NCT02757118
unknownnot_applicable
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for CABG Surgery
NCT02757027
Clinical Trials (4)
Showing 4 of 4 trials
NCT02700607Not Applicable
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity
NCT02770027Not Applicable
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for Colon Surgery
NCT02757118Not Applicable
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for Cardiac Surgery
NCT02757027Not Applicable
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for CABG Surgery
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4